Named on 4 rounds in the feed, most often at Series C.
Rounds from 2026-06-30 to 2026-09-16
| Company | Round | Amount | Announced | Role | Verified |
|---|---|---|---|---|---|
Circle Pharma A biopharmaceutical company advancing CID-165 for ER-positive breast cancer | Series D+ | $92.5M | 2026-09-16 | [ PART ] | 2 |
Thatch A healthcare system | Series C | $108M | 2026-09-15 | [ PART ] | 4 |
Remedium Bio, Inc. A biotechnology company developing durable protein therapeutics | Series A | $10M | 2026-08-09 | [ PART ] | 3 |
Flare Therapeutics A biotech startup targeting transcription factors | Series C | $85M | 2026-06-30 | [ PART ] | 5 |